{"pageContent": "Background: Urinary symptoms and sexual dysfunction are the two most common complaints following prostate radiotherapy. The impact of hypofractionated treatment on sexual function, irritative symptoms, and voiding symptoms has not been determined within the same patient population. Here we present our institutional data on sexual function, voiding function, irritative symptoms, and treatment response following SBRT.", "metaData": {"source": "Sexual bother in men with advanced prostate cancer undergoing androgen deprivation therapy\nhttps://pubmed.ncbi.nlm.nih.gov/25059094/"}}